VOGENX
Live / Applied — Fourth extension granted (statement of use) (as of 27 May 2025)
What this means for you
Not registered yet, but its 29 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97481101
- Mark type
- Stylized text
- Filed
- 29 Jun 2022
- Published for opposition
- 16 May 2023
- Attorney of record
- David R. Lipson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and medical preparations for use in the treatment of rare metabolic diseases
- Class 042 — Scientific and technological services: Scientific and research services related to research and development of therapeutics, pharmaceuticals, and medical preparations for use in the treatment of rare metabolic diseases
Owner
- Vogenx Inc., Durham, NC, US
- Vogenx Inc., Durham, NC, US
Prosecution history
- 08 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 May 2025 — SOU EXTENSION 4 GRANTED
- 27 May 2025 — SOU EXTENSION 4 FILED
- 27 May 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jan 2025 — SOU EXTENSION 3 GRANTED
- 09 Jan 2025 — SOU EXTENSION 3 FILED
- 09 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jun 2024 — SOU EXTENSION 2 GRANTED
- 25 Jun 2024 — SOU EXTENSION 2 FILED
- 25 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 21 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Dec 2023 — SOU EXTENSION 1 GRANTED